May 4, 2025 - 09:35

Billionaire investor Ken Fisher has made headlines with his recent selection of technology stocks that he believes hold significant upside potential. Among these picks is Alibaba Group Holding Limited, a major player in the e-commerce and technology sectors. As 2025 unfolds, technology stocks have experienced considerable volatility, with market sentiment shifting dramatically based on various economic indicators.
Alibaba, listed on the New York Stock Exchange as BABA, finds itself navigating this turbulent landscape alongside other tech giants. Analysts are closely monitoring Alibaba's performance, particularly in light of its innovative strategies and expansion efforts in both domestic and international markets. The company's ability to adapt to changing consumer behaviors and regulatory environments will be crucial in determining its future growth trajectory.
Investors are keen to see how Alibaba will leverage its robust infrastructure and technological advancements to capitalize on emerging trends. With Fisher’s endorsement, many are optimistic about Alibaba's potential to rebound and thrive amidst the ongoing challenges faced by the tech sector.
September 30, 2026 - 21:59
Micron Technology Tops Lofty Fiscal Q4 Goals, Guides Above ViewsMicron Technology exceeded analyst expectations for its fiscal fourth quarter, delivering results that outperformed even the most optimistic projections on Wall Street. The memory chip maker...
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...